• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Socioeconomically disadvantaged older persons are at greater risk of impairments after ICU hospitalization

byDavid XiangandHarsh Shah
March 24, 2022
in Emergency, Imaging and Intervention, Public Health
Reading Time: 2 mins read
Share on FacebookShare on Twitter

1. Socioeconomically disadvantaged older persons are at greater risk for decline in function and cognition after an ICU hospitalization than more advantaged counterparts.

2. Socioeconomically disadvantaged older persons are at greater risk for disability after ICU hospitalization compared to their more advantaged counterparts.

Evidence Rating Level: 2 (Good)

Study Rundown: Post-intensive care syndrome (PICS) is defined as new or worsening impairments in function, cognition, and mental health after a critical illness. Older patients are especially susceptible to these impairments because of their preexisting health concerns such as frailty, cognitive impairment, and sensory deficits. Moreover, the number of older persons staying in an ICU in the US is projected to rise due to the aging population. However, there is a gap in knowledge as to understanding equity in patient-centered outcomes among ICU survivors. This study found that socioeconomic disadvantage among older adults is associated with the decline in function and cognition after ICU hospitalization compared to more socioeconomically advantaged older patients. This study was limited by factors such as administrative data, variability in the timing of baseline and outcome assessments, and proxy selection. Nevertheless, these study’s findings are significant, as they demonstrate that socioeconomically disadvantaged older persons are at greater risk of functional and cognitive decline after an ICU hospitalization.

Click to read the study in AIM

Relevant Reading: Health Equity and Critical Care Survivorship: Where Do We Go From Here?

RELATED REPORTS

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

Neighbourhood socioeconomic status may be associated with days spent at home following hip fracture in older adults

Body mass index and in-hospital mortality have a U-shaped relationship among critically ill cardiac surgery patients

In-Depth [longitudinal cohort study]: This retrospective analysis of a longitudinal cohort study involved community-dwelling older adults in the National Health and Aging Trends Study. Patients who were Medicare beneficiaries aged 65 years or older living in the US were eligible for the study. Patients who were unavailable for an interview or unable to consent to be followed up were excluded from the study. The primary outcome measured was ICU admission, functional assessment, cognitive assessment, and mental health assessment. Socioeconomic disadvantage is defined as dual-eligible Medicare-Medicaid status. Outcomes in the primary analysis were assessed via Poisson regression and logistic regression models as well as sensitivity analysis. Based on the analysis, the sample included 641 ICU hospitalizations for function, 458 for cognition, and 519 for mental health. Among the study sample, the socioeconomic disadvantage was associated with a 28% increase in disability and decline in function after an ICU hospitalization (incidence rate ratio, 1.28; 95% Confidence Interval, 1 to 1.64). Socioeconomic disadvantage was also associated with a nearly 10-fold greater odds of transitioning to probably dementia (odds ratio, 9.79; 95% CI, 3.46 to 27.65). Socioeconomic disadvantage was not associated with symptoms of depression and anxiety after ICU hospitalization (incidence rate ratio, 1.33; 95% CI, 0.99 to 1.79), as post-ICU mental health symptoms were seemingly driven by pre-ICU mental health. Overall, this study demonstrated that socioeconomically disadvantaged older adults have a greater risk of functional and cognitive decline after an ICU hospitalization, highlighting the need to prioritize low-income seniors in rehabilitation and recovery after critical illness.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: elderlyICUICU admissionsocioeconomicsocioeconomic status
Previous Post

#VisualAbstract: Non-severe tuberculosis in children can be treated with a shorter 4-month regimen instead of 6-month regimen

Next Post

SARS-CoV-2 infection during pregnancy associated with severe maternal morbidity, preterm birth, and venous thromboembolism

RelatedReports

Novel coronavirus identified from patients with pneumonia in Wuhan, China
Emergency

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

September 1, 2026
Bisphosphonate use and risk of atypical femur fractures
Orthopedic Surgery

Neighbourhood socioeconomic status may be associated with days spent at home following hip fracture in older adults

January 12, 2026
Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Cardiology

Body mass index and in-hospital mortality have a U-shaped relationship among critically ill cardiac surgery patients

January 13, 2026
Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure
Emergency

Use of etomidate and ketamine is associated with similar rates of peri-intubation hypotension and mortality

January 13, 2026
Next Post
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

SARS-CoV-2 infection during pregnancy associated with severe maternal morbidity, preterm birth, and venous thromboembolism

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Mortality outcomes from ivermectin trials for COVID-19 associated with strongyloidiasis prevalence: a meta-analysis

#VisualAbstract: Melanoma may be considerably over-diagnosed in white patients in the US

#VisualAbstract: Melanoma may be considerably over-diagnosed in white patients in the US

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Brepocitinib becomes first oral therapy approved for adult dermatomyositis
  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.